| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/23/2008 | CN100383155C Stem clasping gut weed lactone and its derivative composition and its preparing method and its use |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383139C Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor |
| 04/23/2008 | CN100383138C Novel n-monoacylated o-phenylenediamines, their condensed heterocyclic derivatives and their use as pharmaceutical agents |
| 04/23/2008 | CN100383132C Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/23/2008 | CN100383128C Ramification of N-carbethoxy cytosine and preparation method and application |
| 04/23/2008 | CN100383111C Method for preparing compound of fluoro aromatic hydrocarbon |
| 04/23/2008 | CN100382846C Method for improved imaging and photodynamic therapy |
| 04/23/2008 | CN100382843C Injection for anti-tumor |
| 04/23/2008 | CN100382822C Herb Chinese medicine for prevention and treatment of tumour |
| 04/23/2008 | CN100382797C Confected product containing lutein and/or carotene linolenic acid, and its preparation method |
| 04/23/2008 | CN100382790C Compound yew drop pills and its preparation method |
| 04/22/2008 | US7361760 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361685 Compounds for use in the treatment of skin conditions |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361677 Polycyclic sulphamate compounds suitable for use as inhibitors of aromatase and/or sulphatase |
| 04/22/2008 | US7361664 For therapy of cancer, hyperparathyroidism, vascular calcification, bone disease, renal failure or kidney stones, psoriasis |
| 04/22/2008 | US7361662 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 04/22/2008 | US7361656 Prenyl transferase inhibitors |
| 04/22/2008 | US7361633 Treating sex-hormone dependent tumors and cancer such as benign prostate hyperplasia and uterine fibroids with the decapeptide: Ac-D-Nal(2)-D-4-ClPhe-D-Pal-Ser-1 MePal-D-IsopropylLys-Leu-lsopropylLys-Pro-D-AlaNH2 |
| 04/22/2008 | US7361511 Comparing gene expression levels in normal and tumor cells, diagnosis, treating with an antisense oligonucleotide, and monitoring results |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361475 Compositions and methods relating to colon specific genes and proteins |
| 04/22/2008 | US7361356 Gene expression in host cell of conformational epitopes; used as elements of diagnostic immunoassay procedures for papillomavirus infection |
| 04/22/2008 | US7361355 Mutant forms of cholera holotoxin as an adjuvant |
| 04/22/2008 | US7361354 Methods for treating malignancies expressing ICAM-1 using coxsackie a group viruses |
| 04/22/2008 | US7361343 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to deposit PTA-4890 at the ATCC |
| 04/22/2008 | US7361342 Cancerous disease modifying antibodies |
| 04/22/2008 | US7361340 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 04/22/2008 | US7361338 Methods to inhibit growth of prostate cancer cells |
| 04/22/2008 | US7361332 Alloactivated lymphocytes in a pharmaceutical excipient; immunotherapy |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |
| 04/22/2008 | CA2318349C Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 04/22/2008 | CA2225807C Use of lamellarin-class alkaloids in methods of treatment |
| 04/22/2008 | CA2174737C Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| 04/22/2008 | CA2112395C Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/17/2008 | WO2008046084A2 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008046065A1 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008046003A2 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 04/17/2008 | WO2008045905A1 Pyrrolydine derivatives as iap inhibitors |
| 04/17/2008 | WO2008045604A2 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 04/17/2008 | WO2008045543A1 Substituted 4h-imidazo [4, 5, 1-ij] [1, 6] naphthyridine-9-amines and their pharmaceutical use |
| 04/17/2008 | WO2008045529A1 Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases |
| 04/17/2008 | WO2008045461A2 Transdermal diethylstilbestrol for treating prostate cancer |
| 04/17/2008 | WO2008045268A2 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2008 | WO2008045267A2 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2008 | WO2008045266A2 Pyrazolopyrimidiwes as cyclin dependent kinase inhibitor |
| 04/17/2008 | WO2008044787A1 Composition for treating cancer using dref as molecular target |
| 04/17/2008 | WO2008044782A2 Combination drug |
| 04/17/2008 | WO2008044754A1 Prophylactic or therapeutic agent for cancer |
| 04/17/2008 | WO2008044704A1 Anti-cancer agent |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044688A1 Urea derivative |
| 04/17/2008 | WO2008044627A1 Prophylactic/therapeutic agent for liver disorder utilizing baculovirus |
| 04/17/2008 | WO2008044076A2 Therapy targeting cathepsin s |
| 04/17/2008 | WO2008044034A1 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 04/17/2008 | WO2008043811A1 Staurosporine derivatives and radiation |
| 04/17/2008 | WO2008043777A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | WO2008043767A1 Antimetastatic effect on human cell disorders |
| 04/17/2008 | WO2008043570A1 Interferon type i supporting compounds |
| 04/17/2008 | WO2008043446A1 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl)]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate |
| 04/17/2008 | WO2008043263A1 Isoxazole derivatives and methods of treating diseases |
| 04/17/2008 | WO2008043148A1 The use of a dna damaging agent and a ligand for the treatment of cancer |
| 04/17/2008 | WO2008027542A3 5-substituted isoindoline compounds |
| 04/17/2008 | WO2008025848A3 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 04/17/2008 | WO2008024337A3 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 04/17/2008 | WO2008024299A3 Combination with bis(thiohydrazide amides) for treating cancer |
| 04/17/2008 | WO2008020455A3 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 04/17/2008 | WO2008002571B1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 04/17/2008 | WO2008002570B1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 04/17/2008 | WO2007147371A3 Pharmaceutical composition for oral administration |
| 04/17/2008 | WO2007135569A3 Methods of treating canine osteosarcoma |
| 04/17/2008 | WO2007127951A3 Compositions and methods involving mda-7 for the treatment of cancer |
| 04/17/2008 | WO2007115286A3 Combinations of therapeutic agents for treating cancer |
| 04/17/2008 | WO2007099377A3 Cancer treatments |
| 04/17/2008 | WO2007094027A3 Methods for the diagnosis of proliferative and/or conformational diseases |
| 04/17/2008 | WO2007085895A3 Fap inhibitors |
| 04/17/2008 | WO2007028341A8 Nano anticancer micelles of vinca alkaloids entrapped in polyethylene glycolylated phospholipids |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080090913 Sphingolipid-Derived Phamaceutical Compositions |
| 04/17/2008 | US20080090907 Crystal Comprising (2R)-2-Propyloctanoic Acid and Amine |
| 04/17/2008 | US20080090904 S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer |
| 04/17/2008 | US20080090893 Use of indoline derivatives such as silodosin to prevent transition to surgical therapy of benign prostatic hyperplasia |
| 04/17/2008 | US20080090887 Triazole compounds that modulate HSP90 activity |
| 04/17/2008 | US20080090883 Hormone-dependent cancers such as breast cancer or prostate cancer; 4-aryl or heteroaryl-substituted 3,3-dioxo-3-thia-4-azatricyclo[5.2.1.02,6]dec-8-ene |
| 04/17/2008 | US20080090880 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators |
| 04/17/2008 | US20080090871 Cannabimimetic indole derivatives |
| 04/17/2008 | US20080090861 Cancer and fibrotic disorders such as scarring prevention; 2-(4-methyl-1-(6-methylpyridin-2-yl)-1H-pyrazol-5-yl)thieno[2,3-c]pyridine for example; activin receptor-like kinase-5 (ALK-5) inhibitors |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090856 useful for the modulation of kinase activity of C-Abl, c-Kit, VEGFR, PDGFR, Flt-3, c-MET, HER family, Raf kinase family and disease polymorphs thereof; hyperproliferative diseases, cancer; 1-(5-(4-(1H-pyrazol-4-yl)pyrimidin-2-yloxy)-2-fluorophenyl)-3-(3-isopropyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)urea |
| 04/17/2008 | US20080090848 Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or Glycerides |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090831 Cytotoxic agents |
| 04/17/2008 | US20080090830 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer |
| 04/17/2008 | US20080090821 Improved solubility, lower tendency to bind to plasma proteins and greater activity especially in serum-based assay systems; remodeling of heart after myocardial infarction; atherosclerosis; 2-[4-(4-Fluorophenoxy)benzenesulfonyl]-6-(2-piperidin-1-ylethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |